EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms

Yang Lyu, Yutong Zhang, Ayana Kon iD

Cancer Science · 2026

DOI: 10.1111/cas.70461 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2026. Verfasst von Yang Lyu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Tumor Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Mutation, RNA Splicing Factors. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Mitsubishi Foundation, Japanese Society of Hematology, The SGH Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Splicing factor (SF) mutations are recurrent driver alterations in myeloid neoplasms and also represent a distinctive class of mutations in clonal hematopoiesis (CH), an age‐associated expansion of hematopoietic clones carrying somatic driver mutations. SF‐mutant CH is characterized by relatively late emergence and accelerated clonal expansion in older individuals. This review summarizes current knowledge of the genetic features and clonal dynamics of SF‐mutant CH. We discuss disease‐associated molecular consequences of SF mutations, including dysregulation of innate immune and inflammatory signaling, R‐loop accumulation associated with replication stress, altered stress granule dynamics, impaired minor intron splicing, and cooperative genetic interactions. We further consider candidate mechanisms that may contribute to age‐dependent selection of SF‐mutant clones during CH, including attenuated interferon responsiveness and telomere‐dependent changes in replicative fitness. Together, current evidence highlights the unique biology of SF‐mutant CH and the unresolved mechanisms underlying its preferential expansion in older individuals. Clarifying these mechanisms may improve risk stratification, inform early‐intervention strategies, and advance our understanding of age‐associated clonal evolution and leukemogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisMutationRNA Splicing FactorsHumansDisease ProgressionAnimalsClonal EvolutionTelomere

Stichwörter der Autor:innen

clonal hematopoiesisclonal selectionmyeloid malignanciessplicing factor mutationstelomere attrition

Substanzen

RNA Splicing Factors

Autor:innen und Institutionen

  • Division of Hematology and Tumor Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Stem Cell and Genome Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Ayana Kon

Förderung

  • The Mitsubishi Foundation
  • Japanese Society of Hematology
  • The SGH Foundation
  • The Japan Philanthropic Foundation
  • The Cell Science Research Foundation
  • The Takeda Science Foundation
  • The Ono Pharmaceutical Foundation for Oncology, Immunology, and Neurology
  • Mitsubishi Foundation

Zitieren

APA

Lyu, Y., Zhang, Y., & Kon, A. (2026). Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms. Cancer Science. https://doi.org/10.1111/cas.70461

Vancouver

Lyu Y, Zhang Y, Kon A. Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms. Cancer Science. 2026. doi:10.1111/cas.70461

BibTeX
@article{Lyu2026,
  author = {Lyu, Yang and Zhang, Yutong and Kon, Ayana},
  title = {Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70461}
}
Kostenlos starten →